To present some immunological aspects of fresh-frozen allogeneic bone grafting for lateral bone augmentation, based on the quantitative evaluation of IL-10, IL-1β, IFN- γ and TNF- α in patients sera. Thirty-three partially or totally edentulous patients received fresh-frozen allogeneic bone (AL - 20 patients) or autologous bone onlay block grafts (AT - 13 patients) prior to oral implant placement. Blood samples were collected from each patient at various time-points during a 6month-period (baseline, 14, 30, 90 and 180days postoperatively). Quantitative evaluation of IL-10, IL-1β, IFN- γ and TNF- α was performed by enzyme linked immunosorbent assay (ELISA). For all evaluated markers and at all evaluated periods, inter-group comparisons showed no statistically significant differences between the groups, while the observed values were within normal levels. For AL-treated patients, intra-group evaluation showed statistically significant increase of TNF-α from baseline to 90 (P<0.001) and 180 (P<0.01) days, and from 14 to 90 (P<0.01) and 180 (P<0.05) days. IFN- γ showed intercalated results, with a decrease from baseline to 14days (P<0.05), and increase from 14 to 90days (P<0.001) and 180 (P<0.05) days. No differences between the periods of evaluation were found for the AT group. AL grafting for lateral bone augmentation, similar to AT grafting, does not seem to challenge the immune system significantly.